SCHEMBL5480029

SCHEMBL5480029

CC1(C)CN(S(=O)(=O)c2ccc(F)cc2)c2cccc(N3CCNCC3)c2O1

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 18/20 0.73
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5479746 0.90 HTR6 (0.74) HTR6
SCHEMBL1136413 0.90 HTR6 (0.70) HTR6
SCHEMBL5482165 0.89 HTR6 (0.67) HTR6MEN1KMT2A
SCHEMBL1536686 0.89 HTR6 (0.61) HTR6
SCHEMBL4473236 0.84 HTR6 (1.00) HTR6
SCHEMBL5483496 0.84 HTR6 (0.71) HTR6
SCHEMBL5485254 0.83 HTR6 (0.64) HTR6
SCHEMBL1136479 0.83 HTR6 (0.68) HTR6
SCHEMBL1136420 0.82 HTR6 (0.72) HTR6
SCHEMBL5480921 0.82 HTR6 (0.62) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694656-B1 BENZOXAZINE DERIVATIVES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2007-08-29 EP disclosed
US-7202241-B2 Benzoxazine derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-04-10 US disclosed
US-7202241-B2 Benzoxazine derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-04-10 US disclosed
US-7202241-B2 Benzoxazine derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2007-04-10 US disclosed
US-20050124613-A1 Benzoxazine derivatives and uses thereof ROCHE PALO ALTO LLC 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124613-A1 Benzoxazine derivatives and uses thereof XDH, CYP4X1, CYP2C9 HTR6 1872/4885MEN1 2184/4885KMT2A 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.